MedCity Influencers Navigating Policy Terrain: Perspectives for Payers on Tackling Ghost Networks By Meghan Gaffney
Hospitals Q1 Was Pretty Good For Hospital Finance — But It’s Unclear If It Will Stay That Way By Katie Adams
MedCity Influencers Navigating the Transition to Value-Based Care: Addressing Fears and Embracing Risk in ACO REACH By Mike Ward
BioPharma, Pharma Amgen Puts Its Weight Behind Obesity Drug With Potential Edge Over Lilly, Novo Nordisk Meds By Frank Vinluan
